Prevention and management of ovarian hyperstimulation syndrome

被引:25
|
作者
Chen, Chin-Der
Chen, Shee-Uan
Yang, Yu-Shih [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan
关键词
ovarian hyperstimulation syndrome; complications; prevention; management; IN-VITRO FERTILIZATION; ENDOTHELIAL GROWTH-FACTOR; APPROACH AGONIST TRIGGER; FINAL OOCYTE MATURATION; GNRH AGONIST; INTRAVENOUS ALBUMIN; CYCLES; ASCITES; WOMEN; RISK;
D O I
10.1016/j.bpobgyn.2012.04.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian hyperstimulation syndrome is a relatively common complication of ovarian stimulation and can be life-threatening. The pathophysiology of ovarian hyperstimulation syndrome is characterised by increased capillary permeability, leading to leakage of fluid from the vascular compartment, with third space fluid accumulation and intravascular dehydration. The combined use of a gonadotrophin-releasing hormone antagonist protocol with gonadotrophin-releasing hormone agonist triggering and oocyte and embryo freezing has considerable promise in preventing ovarian hyperstimulation syndrome. Women with severe ovarian hyperstimulation syndrome require hospitalisation for more careful monitoring and treatment. Transvaginal paracentesis can be used as an outpatient treatment to prevent the need for hospitalisation. The inhibition of vascular permeability seems to be a novel therapeutic approach to preventing and treating ovarian hyperstimulation syndrome. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:817 / 827
页数:11
相关论文
共 50 条
  • [21] Ovarian hyperstimulation syndrome: pathophysiology and prevention
    Nastri, Carolina O.
    Ferriani, Rui A.
    Rocha, Isa A.
    Martins, Wellington P.
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2010, 27 (2-3) : 121 - 128
  • [22] Prevention of Ovarian Hyperstimulation Syndrome by albumin
    Lai, R
    Cau, G
    Floris, M
    Monni, G
    [J]. INFERTILITY AND ASSISTED REPRODUCTIVE TECHNOLOGY: FROM RESEARCH TO THERAPY, 1997, : 361 - 365
  • [23] An update on the prevention of ovarian hyperstimulation syndrome
    El Tokhy, Omar
    Kopeika, Julia
    El-Toukhy, Tarek
    [J]. WOMENS HEALTH, 2016, 12 (05) : 496 - 503
  • [24] Prevention and treatment of ovarian hyperstimulation syndrome
    Dourron, NE
    Williams, DB
    [J]. SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1996, 14 (04): : 355 - 365
  • [25] Prevention of Ovarian Hyperstimulation Syndrome: A Review
    Smith, Vinayak
    Osianlis, Tiki
    Vollenhoven, Beverley
    [J]. OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2015, 2015
  • [26] Prevention of ovarian hyperstimulation syndrome Reply
    Spitzer, Dietmar
    Zech, Nicolas H.
    [J]. FERTILITY AND STERILITY, 2011, 95 (08) : E66 - E66
  • [27] Diosmin for the prevention of ovarian hyperstimulation syndrome
    Li, Tingting
    Zhu, Wanshan
    Liu, Guihua
    Fang, Cong
    Quan, Song
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 149 (02) : 166 - 170
  • [28] Ovarian hyperstimulation syndrome: pathophysiology and prevention
    Carolina O. Nastri
    Rui A. Ferriani
    Isa A. Rocha
    Wellington P. Martins
    [J]. Journal of Assisted Reproduction and Genetics, 2010, 27 : 121 - 128
  • [29] Ovarian Hyperstimulation: Diagnosis, Prevention, and Management
    Levi-Setti, Paolo Emanuele
    Di Segni, Noemi
    Gargasole, Clara
    Ronchetti, Camilla
    Cirillo, Federico
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2021, 39 (05/06) : 170 - 179
  • [30] Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome
    Homburg, R
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) : 773 - 788